ZLAB – zai lab limited - american depositary shares (US:NASDAQ)
Stock Stats
News
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative [Seeking Alpha]
How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen's (AMGN) Risk-Reward Profile [Yahoo! Finance]
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy [Yahoo! Finance]
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
Zai Lab (ZLAB) had its price target lowered by JPMorgan Chase & Co. from $39.00 to $32.00. They now have an "overweight" rating on the stock.
Form 4 Zai Lab Ltd For: Apr 06 Filed by: Edmondson Frazor Titus III
Form 4 Zai Lab Ltd For: Apr 06 Filed by: Smiley Joshua L
Form 4 Zai Lab Ltd For: Apr 06 Filed by: Amado Rafael
Form 4 Zai Lab Ltd For: Apr 06 Filed by: Chen Yajing
Form 4 Zai Lab Ltd For: Apr 06 Filed by: Du Ying
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.